- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01930097
Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes
An Open-label, Randomized, Three-way, Cross-over Study to Compare the Efficacy of Closed-loop Operation Combined With Meal-and-carbohydrate-announcement Closed-loop Operation Combined With Meal-announcement, and Conventional Pump Therapy in Regulating Glucose Levels in Adults With Type 1 Diabetes
Closed-loop strategy is composed of three components: glucose sensor to read glucose levels, insulin pump to infuse insulin and a dosing mathematical algorithm to decide on the required insulin dosage based on the sensor's readings. A dual-hormone closed-loop system would regulate glucose levels through the infusion of two hormones: insulin and glucagon.
The objective of this project is to assess whether a dual-hormone closed-loop strategy would alleviate the burden of carbohydrate counting from patients with type 1 diabetes (T1D) without a significant degradation in post-meal glucose control.
Our primary hypothesis is that meal-announcement strategy (pre-meal CHO-independent bolus) is equivalent to meal-and-carbohydrate-announcement strategy (full CHO-matching bolus) during closed-loop regulation of glucose levels in adults with T1D. Our secondary hypothesis is that closed-loop strategy with meal-announcement strategy (pre-meal CHO-independent bolus) or meal-and-carbohydrate-announcement strategy (full CHO-matching bolus) is better than conventional pump treatment in regulation of glucose levels in adults with T1D.
Přehled studie
Detailní popis
Closed-loop strategy is composed of three components: glucose sensor to read glucose levels, insulin pump to infuse insulin and a dosing mathematical algorithm to decide on the required insulin dosages based on the sensor's readings. A dual-hormone closed-loop system would regulate glucose levels through the infusion of two hormone: insulin and glucagon.
Each patient will be admitted three times to a clinical research facility. In the meal-and-carbohydrate-announcement visit, patients will eat 3 meals accompanied with a matching insulin bolus (depending on the carbohydrate content of the meal) and glucose levels will be subsequently regulated using dual-hormone closed-loop system. In the meal-announcement visit, patients will eat the 3 same meals but will inject only a partial insulin bolus (not depending on carbohydrate content of the meal) and the remaining needed insulin will be delivered based on glucose sensor excursions as part of closed-loop operation. In the control visit, patients will use conventional pump therapy to regulate glucose levels.
Typ studie
Zápis (Aktuální)
Fáze
- Fáze 2
Kontakty a umístění
Studijní místa
-
-
Quebec
-
Montreal, Quebec, Kanada, H2W1R7
- Institut de Recherches Cliniques de Montreal
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Males and females ≥ 18 years of old.
- Clinical diagnosis of type 1 diabetes for at least one year.
- The subject will have been on insulin pump therapy for at least 3 months.
- Last (less than 3 months) HbA1c ≤ 12%.
Exclusion Criteria:
- Clinically significant microvascular complications: nephropathy (estimated glomerular filtration rate below 40 ml/min), neuropathy (especially diagnosed gastroparesis) or severe proliferative retinopathy as judged by the investigator.
- Recent (< 3 months) acute macrovascular event e.g. acute coronary syndrome or cardiac surgery.
- Ongoing pregnancy.
- Severe hypoglycemic episode within two weeks of screening.
- Medication likely to affect with the interpretation of the results because of their well known impact on gastric emptying: Motilium®, Prandase®, Victoza®, Byetta® and Symlin®.
- Known or suspected allergy to the trial products, meal contents including nuts, peanuts, dairy products or eggs.
- Unusual nutritional habits (e.g. vegetarians)
- Other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
- Failure to comply with team's recommendations (e.g. not willing to eat snack, not willing to change pump parameters, etc).
- Unreliable carbohydrate counting or lack of insulin to carbohydrate ratios
- Problems with venous access
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Crossover Assignment
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
---|---|
Aktivní komparátor: CHO-dependant bolus
An insulin bolus dependant of carbohydrate content will be given after each meal. Each subject insulin-to-carbohydrate ratio (U per 10g CHO) will be used to calculate the insulin bolus to be given. The dual-hormone closed-loop strategy will give the remaining insulin needed based on the sensor readings. |
Subjects will be admitted at the IRCM at 6:30.
Subjects will be asked to fast from midnight.
At 8:00, a standardized (50g CHO for males; 30g CHO for females) meal will be served.
At 12:00, a standardized (120g CHO for males; 90g CHO for females) meal will be served.
At 17:00, a standardized (70g CHO for males; 50g CHO for females) meal will be served.
Between meals, patients will be allowed to do sedentary activities (reading, watching television, and playing video games, etc).
|
Aktivní komparátor: CHO-independent bolus
An insulin bolus independent of carbohydrate content will be given after each meal.
The dual-hormone closed-loop strategy will give the remaining insulin needed based on the sensor readings.
|
Subjects will be admitted at the IRCM at 6:30.
Subjects will be asked to fast from midnight.
At 8:00, a standardized (50g CHO for males; 30g CHO for females) meal will be served.
At 12:00, a standardized (120g CHO for males; 90g CHO for females) meal will be served.
At 17:00, a standardized (70g CHO for males; 50g CHO for females) meal will be served.
Between meals, patients will be allowed to do sedentary activities (reading, watching television, and playing video games, etc).
|
Aktivní komparátor: Conventional treatment
Patients will use conventional pump therapy to regulate glucose levels
|
Subjects will be admitted at the IRCM at 6:30.
Subjects will be asked to fast from midnight.
At 8:00, a standardized (50g CHO for males; 30g CHO for females) meal will be served.
At 12:00, a standardized (120g CHO for males; 90g CHO for females) meal will be served.
At 17:00, a standardized (70g CHO for males; 50g CHO for females) meal will be served.
Between meals, patients will be allowed to do sedentary activities (reading, watching television, and playing video games, etc).
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
The positive incremental area under the curve of postprandial glucose excursions
Časové okno: 4 hours after meal intake
|
The positive incremental area under the curve (IAUC, as compared to pre-meal glucose value) of the 4-hr postprandial glucose excursions for the breakfast, lunch and dinner meals.
|
4 hours after meal intake
|
Sekundární výstupní opatření
Měření výsledku |
Časové okno |
---|---|
Mean plasma glucose
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Incremental two hours postprandial glucose
Časové okno: 2 hours after meal intake
|
2 hours after meal intake
|
Incremental postprandial peak-glucose values
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Percentage of time of plasma glucose levels between 4.0 and 10.0 mmol/L
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Percentage of time of plasma glucose levels spent above 10.0 mmol/L
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Percentage of time of plasma glucose levels spent below 4.0 mmol/L
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Total insulin delivery
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Total glucagon delivery
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Standard deviation of glucose levels
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Percentage of time of plasma glucose concentrations below 3.5 mmol/L
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Percentage of time of plasma glucose concentrations above 14 mmol/L
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Mean plasma insulin concentration
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Mean plasma glucagon concentration
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Number of patients experiencing hypoglycemia requiring oral treatment
Časové okno: 8h00 to 21h00
|
8h00 to 21h00
|
Incremental area under the curve of the 4-hr postprandial glucose excursions but the reference glucose is set to 5.0 mmol/L if premeal glucose is less than 5.0 mmol/L.
Časové okno: 4 hours after meal intake
|
4 hours after meal intake
|
Spolupracovníci a vyšetřovatelé
Spolupracovníci
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- CLASS-05
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Diabetes typu 1
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustZatím nenabíráme
-
Hoffmann-La RocheDokončenoDiabetes 2. typu, Diabetes 1. typuRakousko, Spojené království
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Nábor
-
Oshadi Drug AdministrationDokončenoDiabetes Mellitus | Závislá na inzulínu | Typ 1Izrael
-
Duke UniversityDokončenoHyperglykémie | Kardiovaskulární onemocnění | Diabetes, typ 2 | Diabetes, typ 1Spojené státy
-
Technical University of MunichLudwig-Maximilians - University of Munich; Technische Universität Dresden; Helmholtz...Aktivní, ne nábor
-
Capillary Biomedical, Inc.UkončenoDiabetes typu 1 | Diabetes mellitus 1. typu | Diabetes Mellitus, typ I | Diabetes Mellitus, závislý na inzulínu, 1 | IDDMRakousko
-
KU LeuvenDokončeno
-
University of California, San FranciscoJuvenile Diabetes Research FoundationDokončenoDiabetes mellitus 1. typu | Diabetes Mellitus, typ I | Diabetes mellitus závislý na inzulínu 1 | Diabetes Mellitus, závislý na inzulínu, 1 | IDDMSpojené státy, Austrálie
-
Zhejiang Provincial People's HospitalZatím nenabírámeCukrovka typu 2 | diabetes typu 1Čína
Klinické studie na 14 hours intervention
-
Oregon Research InstituteDokončenoZneužívání návykových látekSpojené státy
-
Sarah BlaylockVA Office of Research and DevelopmentDokončenoPodzim | Nízké viděníSpojené státy
-
Idaho State UniversityZatím nenabírámeExperimentální videohry | Hodnocení chování
-
University of Illinois at Urbana-ChampaignDokončenoStárnutí | Mírná kognitivní porucha | Dobře stárnoutSpojené státy
-
Brigham and Women's HospitalNational Institute on Aging (NIA)DokončenoRevmatická onemocnění | Lupus erythematodes, systémový | Adherence, léky | DnaSpojené státy
-
Anadolu UniversityEskisehir Osmangazi UniversityZatím nenabíráme
-
Charite University, Berlin, GermanyAssociation of Statutory Health Insurance Physicians (KV Berlin); Statutory... a další spolupracovníciAktivní, ne náborArterioskleróza | Cukrovka typu 2 | Poruchy metabolismu lipidů | Arteriální hypertenzeNěmecko
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of California, Los Angeles a další spolupracovníciDokončenoHIV infekce | Pohlavně přenášená nemocSpojené státy
-
University of Colorado, DenverKaiser Permanente; Itamar-Medical, IsraelDokončenoSyndromy spánkové apnoe | Porucha spánku | SpátSpojené státy
-
Georgetown UniversityZatím nenabírámeRakovina | Parodontální onemocnění | Orální mukositida